Status:

COMPLETED

Safety and Efficacy Trial of Recombinant Human Granulocyte Colony Stimulating Factor (GCSF)

Lead Sponsor:

Shantha Biotechnics Limited

Conditions:

Chemotherapy-Induced Neutropenia

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

A Phase III Randomized Controlled Open Label Comparative Multicentric Trial To Compare The Safety And Efficacy of Indigenous Recombinant Human Granulocyte Colony Stimulating Factor (rhG-CSF) With Neup...

Eligibility Criteria

Inclusion

  • Patients of either sex aged 18 yrs or more
  • Patients diagnosed having any malignancy (except myeloid malignancies and myelodysplastic syndromes) receiving standard combination chemotherapy.
  • Patients experiencing neutropenia (absolute neutrophil count \< 1000/mm3) in a previous chemotherapy cycle and have one more cycle of chemotherapy on the same drugs.
  • Patients should have performance status of 0-2 ECOG (European Cooperative Oncology group).

Exclusion

  • Patients unwilling to give informed consent or unable to follow study procedures
  • Patients requiring autologous or allogenic stem cell transplantation.
  • Patients having active infection
  • Patients who have taken antibiotics or colony stimulation factor within the previous 10 days
  • Patients who have clinically significant uncontrolled medical illness except malignancy
  • Patients having renal impairment (serum creatinine \> 1.5 times the upper normal limit) and abnormal liver function (bilirubin \> 5 times the upper limit of normal)
  • Pregnant or lactating women
  • Patients who have involvement of bone marrow
  • Patients receiving simultaneous radiotherapy

Key Trial Info

Start Date :

October 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2009

Estimated Enrollment :

126 Patients enrolled

Trial Details

Trial ID

NCT00776165

Start Date

October 1 2007

End Date

September 1 2009

Last Update

February 3 2010

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Indo American Cancer Institute and Research Centre

Hyderabad, Andhra Pradesh, India, 500034

2

Nizam's Institute of Medical Sciences

Hyderabad, Andhra Pradesh, India, 500034

3

Vedanta Institute of Medical Sciences

Ahmedabad, Gujarat, India, 380009

4

Lakeshore Hospital and Research Center

Kochi, Kerala, India, 682404